These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 6926836
1. Influence of food on the bioavailability of "real" and "apparent" hydralazine from conventional and slow-release preparations. Liedholm H, Wåhlin-Boll E, Hanson A, Melander A. Drug Nutr Interact; 1982; 1(4):293-302. PubMed ID: 6926836 [Abstract] [Full Text] [Related]
2. Influence of food intake on the bioavailability of urapidil in healthy volunteers. Kirsten R, Nelson K, Molz KH, Gielsdorf W, Haerlin R. Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):298-301. PubMed ID: 2737799 [Abstract] [Full Text] [Related]
3. ColoPulse tablets perform comparably in healthy volunteers and Crohn's patients and show no influence of food and time of food intake on bioavailability. Maurer JM, Schellekens RC, van Rieke HM, Stellaard F, Wutzke KD, Buurman DJ, Dijkstra G, Woerdenbag HJ, Frijlink HW, Kosterink JG. J Control Release; 2013 Dec 28; 172(3):618-24. PubMed ID: 24096020 [Abstract] [Full Text] [Related]
4. Enhancement of hydralazine bioavailability by food. Melander A, Danielson K, Hanson A, Rudell B, Scherstén B, Thulin T, Wåhlin E. Clin Pharmacol Ther; 1977 Jul 28; 22(1):104-7. PubMed ID: 872490 [Abstract] [Full Text] [Related]
5. Bioavailability of oxazepam: absence of influence of food intake. Melander A, Danielson K, Vessman J, Wählin E. Acta Pharmacol Toxicol (Copenh); 1977 May 28; 40(5):584-8. PubMed ID: 577372 [Abstract] [Full Text] [Related]
6. Pharmacokinetics of dixyrazine: low bioavailability, improved by food intake. Liedholm H, Lidén A, Kroon L, Melander A, Wåhlin-Boll E. Drug Nutr Interact; 1985 May 28; 3(2):87-92. PubMed ID: 3987521 [Abstract] [Full Text] [Related]
7. Influence of food on relative bioavailability of fluoride in man from Na2FPO3-containing tablets for the treatment of osteoporosis. Trautner K. Int J Clin Pharmacol Ther Toxicol; 1989 May 28; 27(5):242-9. PubMed ID: 2737790 [Abstract] [Full Text] [Related]
8. Erratic absorption of a slow-release theophylline sprinkle product. Pedersen S, Møller-Petersen J. Pediatrics; 1984 Oct 28; 74(4):534-8. PubMed ID: 6483520 [Abstract] [Full Text] [Related]
9. Influence of food on the pharmacokinetics of a new multiple unit sustained release sodium valproate formulation. Retzow A, Vens-Cappell B, Wangemann M. Arzneimittelforschung; 1997 Dec 28; 47(12):1347-50. PubMed ID: 9450162 [Abstract] [Full Text] [Related]
10. Influence of food on the bioavailability of a carbamazepine slow-release formulation. Retzow A, Schürer M, Schulz HU. Int J Clin Pharmacol Ther; 1997 Dec 28; 35(12):557-60. PubMed ID: 9455713 [Abstract] [Full Text] [Related]
11. Influence of food intake on the bioavailability of zimeldine and its active metabolite, norzimeldine. Wahlén A, Westerlund D, Wåhlin-Boll E, Melander A. Drug Nutr Interact; 1983 Dec 28; 2(3):175-81. PubMed ID: 6236068 [Abstract] [Full Text] [Related]
12. Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying. Weitschies W, Friedrich C, Wedemeyer RS, Schmidtmann M, Kosch O, Kinzig M, Trahms L, Sörgel F, Siegmund W, Horkovics-Kovats S, Schwarz F, Raneburger J, Mönnikes H. Eur J Pharm Biopharm; 2008 Oct 28; 70(2):641-8. PubMed ID: 18582572 [Abstract] [Full Text] [Related]
13. The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations. Pargal A, Kelkar MG, Nayak PJ. Biopharm Drug Dispos; 1996 Aug 28; 17(6):511-9. PubMed ID: 8866042 [Abstract] [Full Text] [Related]
14. Study on the influence of food on the absorption of theophylline from a controlled-release preparation. Pabst G, Weber W, Müller M, Barkworth MF. Arzneimittelforschung; 1994 Mar 28; 44(3):333-7. PubMed ID: 8192698 [Abstract] [Full Text] [Related]
15. Influence of food intake on the bioavailability of zuclopenthixol. Aaes-Jørgensen T, Liedholm H, Melander A. Drug Nutr Interact; 1987 Mar 28; 5(3):157-60. PubMed ID: 3691322 [Abstract] [Full Text] [Related]
16. Impairment of captopril bioavailability by concomitant food and antacid intake. Mäntylä R, Männistö PT, Vuorela A, Sundberg S, Ottoila P. Int J Clin Pharmacol Ther Toxicol; 1984 Nov 28; 22(11):626-9. PubMed ID: 6389377 [Abstract] [Full Text] [Related]
17. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets. Gai MN, Isla A, Andonaegui MT, Thielemann AM, Seitz C. Int J Clin Pharmacol Ther; 1997 Dec 28; 35(12):565-71. PubMed ID: 9455715 [Abstract] [Full Text] [Related]
18. Complete bioavailability and lack of food-effect on pharmacokinetics of gliclazide 30 mg modified release in healthy volunteers. Delrat P, Paraire M, Jochemsen R. Biopharm Drug Dispos; 2002 May 28; 23(4):151-7. PubMed ID: 12015789 [Abstract] [Full Text] [Related]
19. Hydralazine in arterial hypertension. Randomized double-blind comparison of conventional/Slow-Release formulation and of b.i.d./q.i.d. dosage regimens. Wulff K, Lenz K, Krogsgaard AR, Holst B. Acta Med Scand; 1980 May 28; 208(1-2):49-54. PubMed ID: 7435247 [Abstract] [Full Text] [Related]
20. Relative bioavailability of immediate- and sustained-release hydralazine formulations. Ludden TM, Rotenberg KS, Ludden LK, Shepherd AM, Woodworth JR. J Pharm Sci; 1988 Dec 28; 77(12):1026-32. PubMed ID: 3244106 [Abstract] [Full Text] [Related] Page: [Next] [New Search]